Consensus REGENXBIO Inc.

Equities

RGNX

US75901B1070

Market Closed - Nasdaq Other stock markets 04:00:02 2024-04-18 pm EDT			5-day change	1st Jan Change
16.09 ^USD	-5.52%		-15.40%	-10.36%

Mar. 28	REGENXBIO Inc. Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD	CI
Mar. 18	Transcript : REGENXBIO Inc. Presents at UBS Virtual CNS Day 2024, Mar-18-2024 03:30 PM

Evolution of the average Target Price on REGENXBIO Inc.

Price target over the last 5 years

History of analyst recommendation changes

07d2cf9.5sbB52UHyI_kkyadMYp8bg2bbmXXjbp_oncGQ8WhEsI.3qqSjwdC-8Go60XWBsExXX3uWDS269gU0RZvGZrgfJWRoo2NEl653Jz0RQ~0d65910ac9cfc09f7a45d208a6f064b2

Analyst Recommendations on REGENXBIO Inc.

HC Wainwright Initiates REGENXBIO With Buy Rating, $36 Price Target	Mar. 11	MT
RBC Upgrades REGENXBIO to Outperform From Sector Perform, Lifts Price Target to $35 From $20, 'Impressed by Recent Execution,' Keeps Speculative Risk	Mar. 08	MT
Leerink Partners Upgrades REGENXBIO to Outperform From Market Perform	Mar. 06	MT
Baird Adjusts Price Target on REGENXBIO to $39 From $34, Maintains Outperform Rating	Mar. 06	MT
UBS Cuts REGENXBIO Price Target to $43 From $47, Maintains Buy Rating	Jan. 17	MT
Wedbush Lifts REGENXBIO's PT to $21 From $20 After Higher-Than-Expected Q3 Revenue, Announced Restructuring; Keeps Neutral Rating	Nov. 14	MT
Stifel Initiates REGENXBIO With Buy Rating, Price Target is $35	Nov. 01	MT
Morgan Stanley Adjusts Price Target on REGENXBIO to $42 From $43, Maintains Overweight Rating	23-08-29	MT
Baird Initiates REGENXBIO at Outperform With $42 Price Target	23-06-02	MT
Morgan Stanley Adjusts Price Target on Regenxbio to $43 From $46, Maintains Overweight Rating	23-05-09	MT
Chardan Research Lowers REGENXBIO's Price Target to $55 From $61, Buy Rating Kept	23-05-05	MT
Wedbush Trims REGENXBIO's Price Target to $20 From $21, Keeps Neutral Rating	23-05-05	MT
RBC Cuts Price Target on REGENXBIO to $20 From $22, Maintains Sector Perform, Speculative Risk	23-05-04	MT
RBC Capital Adjusts REGENXBIO Price Target to $22 From $25, Maintains Sector Perform - Speculative Risk Rating	23-04-06	MT
Morgan Stanley Trims Price Target on REGENXBIO to $46 From $50, Maintains Overweight Rating	23-03-06	MT
Wedbush Raises REGENXBIO's Price Target to $21 From $18 After Including RGX-111/MPS I in Model., Keeps Neutral Rating	23-03-01	MT
SVB Securities Adjusts Price Target on REGENXBIO to $14 From $15, Maintains Market Perform Rating	23-01-23	MT
Morgan Stanley Adjusts Price Target on REGENXBIO to $50 From $52, Maintains Overweight Rating	22-11-21	MT
SVB Securities Adjusts Price Target on REGENXBIO to $14 From $13, Maintains Market Perform Rating	22-11-04	MT
RBC Lowers REGENXBIO's PT to $25 From $29, Keeps Sector Perform, Speculative Risk Rating	22-11-04	MT
Chardan Lowers Price Target on REGENXBIO to $61 From $70, Maintains Buy Rating	22-11-04	MT
Wedbush Lowers REGENXBIO's Price Target to $18 From $28, Notes Lack of Catalysts Over Next 12 Months; Keeps Neutral Rating	22-11-04	MT
RBC Capital Adjusts REGENXBIO's Price Target to $29 from $47, Maintains Sector Perform Rating	22-10-04	MT
Wedbush Adjusts Price Target on REGENXBIO to $28 From $32, Maintains Neutral Rating	22-10-04	MT
Morgan Stanley Raises REGENXBIO's Price Target to $52 From $46, Maintains Overweight Rating	22-09-09	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

16.11 USD

Average target price

39.83 USD

Spread / Average Target

+147.26%

High Price Target

55 USD

Spread / Highest target

+241.40%

Low Price Target

21 USD

Spread / Lowest Target

+30.35%

Consensus detail

Consensus revision (last 18 months)

Analysts covering REGENXBIO Inc.

HC Wainwright
RBC Capital Markets
Baird
Leerink Partners
UBS
Wedbush
Stifel Nicolaus
Morgan Stanley
Chardan Research
SVB Securities LLC
Berenberg Bank
SVB Leerink
Chardan
Barclays

Ratings for REGENXBIO Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar